Inhibition of prostate carcinoma specific, tumor infiltrating effector lymphocytes could be reversed and CD8+ cytotoxicity and tumor cell apoptosis increased upon arginase and NOS inhibition in a murine tumor model [14]. The gene discussed is CD8A; the disease is prostate carcinoma.